| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.093 | 0.2 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |